Dimethyl Fumarate Enteric-coated Capsules

DRUG3 trials

Sponsors

Qilu Pharmaceutical (Hainan) Co., Ltd., Nanjing Medical University

Conditions

Relapsing Multiple SclerosisType 1 DiabetesType 1 Diabetes Mellitus

Phase 2

Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes

RecruitingNCT07548996

Nanjing Medical UniversityType 1 Diabetes Mellitus

Start: 2026-04-27End: 2028-12-31Target: 96Updated: 2026-07-21

Phase 3

Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus

RecruitingNCT07258394

Nanjing Medical UniversityType 1 Diabetes

Start: 2026-01-27End: 2028-12-31Target: 90Updated: 2026-03-05

Phase 4

A Phase IV Study of Dimethyl Fumarate Enteric-coated Capsules for Relapsing Multiple Sclerosis (RMS)

Not yet recruitingNCT07138833

Qilu Pharmaceutical (Hainan) Co., Ltd.Relapsing Multiple Sclerosis

Start: 2025-09-30End: 2028-08-31Target: 50Updated: 2025-08-24